References
- Zerres K., Rudnik-Schöneborn S., Steinkamm C., Mücher G. Autosomal recessive polycystic kidney disease. Nephrol. Dial. Transplant. 1996; 11(suppl 6)S29–S33
- Zerres K., Rudnik-Schöneborn S., Mücher G. Autosomal recessive polycystic kidney disease: clinical features and genetics. Adv. Nephrol. 1996; 25: 147–157
- Fick G.M., Gabow P.A. Hereditary and acquired cystic disease of the kidney. Kidney Int. 1994; 46: 951–964
- Shaikewitz S.T., Chapman A. Autosomal recessive polycystic kidney disease: issues regarding the variability of clinical presentation. J. Am. Soc. Nephor. 1993; 3: 1858–1862
- Bates C.M., Baum M., Hunchik M., Quan A. Acute vision loss in children with autosomal recessive polycystic kidney disease. Am. J. Kidney Dis. 1999; 34: 1125–1128
- Neumann H.P., Krumme B., van Velthoven V., Orszagh M., Zerres K. Multiple intracranial aneurysms in a patient with autosomal recessive polycystic kidney disease. Nephrol. Dial. Transplant. 1999; 14: 936–939
- Revai T., Harmos G. Steroid-sensitive nephrotic syndrome and minimal-change nephropathy associated with autosomal-recessive polycystic kidney disease. Clin. Nephrol. 1999; 52: 65
- Ratter S.J., Lowry P.J., Besser G.M., Rees L.H. Chromatographic characterization of adrenocorticotrophin in human plasma. J. Endocrinol. 1980; 85: 359–369
- Service F.J. Hypoglycemic disorders. N. Engl. J. Med. 1995; 332: 44–1152
- Fischer K.F., Lees J.A., Newman J.H. Hypoglycemia in hospitalized patients: causes and outcomes. N. Engl. J. Med. 1986; 315: 1245–1250
- Dizon A.M., Kowalyk S., Hoogwerf B.J. Neuroglycopenic and other symptoms in patients with insulinomas. Am. J. Med. 1999; 106: 307–310
- Stacpoole P.W., Interlandi J.W., Nicholson W.E., Rabin D. Isolated ACTH deficiency: a heterogenous disorder. Critical review and report of four new cases. Medicine 1982; 61: 13–24
- Steer P., Marnell R., Werk E.E., Jr. Clinical alcohol hypoglycemia and isolated adrenocorticotropic hormone deficiency. Ann. Intern. Med. 1969; 71: 343–348
- Yamakita N., Murai T., Kawamura S., Teramachi H., Matsuhisa T., Hirata T., Ikeda T., Morita H., Mune T., Yasuda K. High molecular weight corticotropin measured with immunoradiometric assay in a patient with asymptomatic pituitary corticotropinoma. Endocr. J. 1999; 46: 563–571
- Reincke M., Allolio B., Saeger W., Kaulen D., Winkelman W. A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. J. Clin. Endocrinol. Metab. 1987; 65: 1296–1300
- Hashimoto K., Kaneda T., Nagano I., Asaba K., Takeda K., Takao T. Pituitary adenoma showing intermittent secretion of high molecular weight adrenocorticotropin without evidence of Cushing's disease. Horm. Res. 1999; 52: 39–44
- Richards W.G., Sweeney W.E., Yoder B.K., Wilkinson J.E., Woychik R.P., Avner E.D. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J. Clin. Invest. 1998; 101: 935–939
- Polk D.H., Gore-Ervin M., Padbury J.F., Lam R.W., Reviczky A.L., Fisher D.A. Epidermal growth factor acts as a corticotropin-releasing factor in chronically catheterized lambs. J. Clin. Invest. 1987; 79: 984–988
- Luger A., Calogero A.E., Kalogeras K., Gallucci W.T., Gold P.W., Loviaux D.L., Chrousos G.P. Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance. J. Clin. Endocrinol. Metab. 1988; 66: 334–337